Insider trading window closed ahead of H2 FY26 results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.2%Reaction day

₹164.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-5.2% vs market

Pharmaceuticals peers, median of 173sector+0.5%-4.6% vs sector

On the reaction day the stock moved 5.2 pts less than Nifty Microcap 250 and 4.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.2+1.0-5.2+0.5-4.6

Next day

-4.2+0.8-4.9-0.3-3.9

-5.1-0.5-4.6-1.3-3.8

—-0.5—-1.6—

+4.4+0.8+3.6-1.1+5.5

+14.0+0.5+13.5-1.2+15.2

+2.2-2.0+4.1-3.3+5.5

15d

-9.6-6.4-3.3-7.2-2.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Speciality Medicines Limited has closed its insider trading window from October 1, 2026, until 48 hours after the declaration of unaudited standalone financial results for the half year ended September 30, 2026. This is a routine compliance action under SEBI insider trading rules and BSE circulars.

Likely market impact

Routine regulatory disclosure; signals upcoming half-yearly results announcement but no direct share price impact expected.